Google partners with Apollo Hospitals to launch ‘Symptom Search’
It has recently b...
With the vast majority of the global population ‘Googling’ their health symptoms before visiting a doctor, India is no exception.
It has recently been revealed that Google has partnered with Apollo Hospitals to launch its “Symptom Search” feature. Available solely in India, it enables users to source information regarding commonly searched symptoms within the country. These range from soughs, to pneumonia and chest infections.
Available in both English and Hindi, the smartphone application will present cards which will provide an overview and symptoms on how to treat an illness at home, or whether it will require a visit to the GP.
“Apollo Hospitals has always been committed to empowering individuals with knowledge and involving them in their own care,” explained Sangita Reddy, Joint Managing Director, Apollo Hospitals.
- Apple is set to establish its own health clinics for its employees
- The M-Tiba app is revolutionising healthcare in Kenya
- Apollo Hospitals will support healthcare startups with signed MoU with IBM
“This is a significant trend and we are happy to have partnered on this initiative with Google. At Apollo Hospitals, we have always made optimal use of digital technology for the benefit of patients. The abundant experience and expertise of our consultants was drawn towards providing clinical validation of the symptoms to spread the message of awareness and prevention of diseases.
With the launch of the Symptom Search Project, we aim to provide quality healthcare information which can be accessed by a billion Indians.”
The news follows on from recent reports that Google is set to move into population health management. Its sister company, Verily, will work with insurers when bidding for new contracts, utilising data analytics to take escalating healthcare costs, complex regulations and security concerns.
Providing ample opportunity for the technology giant, tapping into such a lucrative market could see the company develop tailored solutions and remain ahead of the curve.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”